Genetic and epigenetic influences associated with intrauterine growth restriction due to in utero tobacco exposure

Pediatric Endocrinology Reviews

Volumn 8, Issue 2, 2010, Pages 94-102

  Suter, Melissa ^a   Abramovici, Adi ^a   Aagaard Tillery, Kjersti ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Epigenetics; Fetal birth weight; Genetics; In utero tobacco exposure

Indexed keywords

TOBACCO SMOKE;

ADVERSE OUTCOME; DNA POLYMORPHISM; ENVIRONMENTAL EXPOSURE; EPIGENETICS; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; GENOMICS; HUMAN; INTRAUTERINE GROWTH RETARDATION; LOW BIRTH WEIGHT; MATERNAL SMOKING; PHENOTYPE; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURITY; REVIEW; TOBACCO;

EPIGENESIS, GENETIC; FEMALE; FETAL GROWTH RETARDATION; HUMANS; INFANT, NEWBORN; PRE-ECLAMPSIA; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SMOKING;

EID: 78650412871     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. Hammoud, AO, Bujold E, Sorokin Y, Schild C, Krapp M, and Baumann P. Smoking in pregnancy revisited: findings from a large population-based study. Am J Obstet Gynecol 2005;192:1856-1862; discussion 1853-1862
2. Kyrklund-Blomberg NB, and Cnattingius S. Preterm birth and maternal smoking: risks related to gestational age and onset of delivery. Am J Obstet Gynecol 1998;179:1051-1055 (Pubitemid 28489307)
3. Cnattingius S, Granath F, Petersson G, and Harlow BL. The influence of gestational age and smoking habits on the risk of subsequent preterm deliveries. N Engl J Med 1999;341:943-948
4. Peacock JL, Bland JM, and Anderson HR. Preterm delivery: effects of socioeconomic factors, psychological stress, smoking, alcohol, and caffeine. BMJ 1995;311:531-535
5. Peacock JL, Cook DG, Carey IM, Jarvis MJ, Bryant, AE, Anderson, HR, and Bland, JM. Maternal cotinine level during pregnancy and birthweight for gestational age. Int J Epidemiol 1998;27:647-656
6. Cnattingius S. The epidemiology of smoking during pregnancy: smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicotine Tob Res 6 Suppl 2,2004;S125-140
7. Women and smoking: a report of the Surgeon General. Executive summary.MMWR Recomm Rep 2002;51:i-iv;1-13
8. Simpson WJ. A preliminary report on cigarette smoking and the incidence of prematurity. Am J Obstet Gynecol 1957;73:807-815
9. Aagaard-Tillery, KM, Porter, TF, Lane, RH, Varner, MW, and Lacoursiere, DY. In utero tobacco exposure is associated with modified effects of maternal factors on fetal growth. Am J Obstet Gynecol 2008;198:66 e61-66
10. Voigt M, Briese V, Jorch G, Henrich W, Schneider KT, and Straube S. The influence of smoking during pregnancy on fetal growth. Considering daily cigarette consumption and the SGA rate according to length of gestation. Z Geburtshilfe Neonatol 2009;213:194-200
11. Nordstrom ML, and Cnattingius S. Smoking habits and birthweights in two successive births in Sweden. Early Hum Dev 1994;37:195-204 (Pubitemid 24190914)
12. Cooke, RW. Smoking, intra-uterine growth retardation and sudden infant death syndrome. Int J Epidemiol 1998;27:238-241
13. Andersen MR, Simonsen U, Uldbjerg N, Aalkjaer C, and Stender S. Smoking cessation early in pregnancy and birth weight, length, head circumference, and endothelial nitric oxide synthase activity in umbilical and chorionic vessels: an observational study of healthy singleton pregnancies. Circulation 2009;119:857-864
14. Aagaard-Tillery K, Spong CY, Thom E, Sibai B, Wendel G Jr., Wenstrom K, Samuels P, Simhan H, Sorokin Y, Miodovnik M, Meis P, O'Sullivan MJ, Conway D, Wapner RJ. Pharmacogenomics of maternal tobacco use: metabolic gene polymorphisms and risk of adverse pregnancy outcomes. Obstet Gynecol 2010;115:568-577
15. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Kirmeyer, S. Births: final data for 2004. Natl Vital Stat Rep 2006;55:1-101
16. Steer PJ. The epidemiology of preterm labour--why have advances not equated to reduced incidence? BJOG 2006;113 2006;Suppl 3:1-3
17. Naeye RL. Effects of maternal cigarette smoking on the fetus and placenta. Br J Obstet Gynaecol, 1978;85:732-737
18. Nymand G. Letter: Maternal smoking and immunity. Lancet, 1974; 2:1379-1380
19. Hoffman DR, Romero R, and Johnston JM. Detection of platelet-activating factor in amniotic fluid of complicated pregnancies. Am J Obstet Gynecol 1990;162:525 528
20. Harger JH, Hsing AW, Tuomala RE, Gibbs RS, Mead PB, Eschenbach DA, Knox GE, Polk BF. Risk factors for preterm premature rupture of fetal membranes: a multicenter case-control study. Am J Obstet Gynecol 1990;163:130-137
21. Hadley CB, Main DM, Gabbe SG. Risk factors for preterm premature rupture of the fetal membranes. Am J Perinatol 1990;7:374-379 (Pubitemid 20375594)
22. Bainbridge, SA, Sidle, EH, and Smith, GN. Direct placental effects of cigarette smoke protect women from pre-eclampsia: the specific roles of carbon monoxide and antioxidant systems in the placenta. Med Hypotheses 2005;64:17-27
23. Janakiraman, V, Gantz, M, Maynard, S, and El-Mohandes, A. Association of cotinine levels and preeclampsia among African-American women. Nicotine Tob Res 2009;11:679-684
24. Jeyabalan A, Powers RW, Durica AR, Harger GF, Roberts JM, Ness RB. Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia. Am J Hypertens 2008;21:943-947
25. Miller EC, Cao H, Wu Wen S, Yang Q, Lafleche J, and Walker M. The risk of adverse pregnancy outcomes is increased in preeclamptic women who smoke compared with nonpreeclamptic women who do not smoke. Am J Obstet Gynecol 2010;203:334:1-8
26. Karcaaltincaba D, Kandemir O, Yalvac S, Guven ES, Yildirim BA, and Haberal A. Cigarette smoking and pregnancy: results of a survey at a Turkish women's hospital in 1,020 patients. J Obstet Gynaecol 2009;29:480-486
27. Brunnemann, KD, Hoffmann D. Analytical studies on tobacco-specific N-nitrosamines in tobacco and tobacco smoke. Crit Rev Toxicol 1991;21:235-240
28. Haritash AK, Kaushik CP. Biodegradation aspects of polycyclic aromatic hydrocarbons (PAHs): a review. J Hazard Mater 2009;169:1-15
29. Harrison, RM, Delgado-Saborit, JM, Baker, SJ, Aquilina, N, Meddings, C, Harrad, S, Matthews, I, Vardoulakis, S, and Anderson, HR. Measurement and modeling of exposure to selected air toxics for health effects studies and verification by biomarkers. Res Rep Health Eff Inst 2009;3-96; discussion 97-100
30. Stellman SD, Djordjevic MV. (2009) Monitoring the tobacco use epidemic II: The agent: Current and emerging tobacco products. Prev Med 48, S11-15
31. Shimada T. Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons. Drug Metab Pharmacokinet 2006;21:257-276
32. Sellers EM, Tyndale RF, and Fernandes LC. Decreasing smoking behaviour and risk through CYP2A6 inhibition. Drug Discov Today 2003;8:487-493
33. Kohle, C, and Bock, KW. Coordinate regulation of Phase I and II xenobiotic metabolisms by the Ah receptor and Nrf2. Biochem Pharmacol 2007;73:1853-1862
34. Hayes, JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 2000;61:154-166
35. Vasiliou V, Ross D, Nebert DW. Update of the NAD(P)H:quinone oxidoreductase (NQO) gene family. Hum Genomics 2006;2:329-335
36. Wang, X, Zuckerman, B, Pearson, C, Kaufman, G, Chen, C, Wang, G, Niu, T, Wise, PH, Bauchner, H, and Xu, X. Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. JAMA 2002;287:195-202
37. Kawajiri K, Nakachi K, Imai K, Yoshii A, Shinoda N, and Watanabe J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Lett 1990;263:131-133
38. Tsai HJ, Liu X, Mestan K, Yu Y, Zhang S, Fang Y, Pearson C, Ortiz K, Zuckerman, B, Bauchner, H, Cerda, S, Stubblefield, PG, Xu X, Wang, X. Maternal cigarette smoking, metabolic gene polymorphisms, and preterm delivery: new insights on GxE interactions and pathogenic pathways. Hum Genet 2008;123:359-369
39. Nukui T, Day RD, Sims CS, Ness RB, Romkes M. Maternal/newborn GSTT1 null genotype contributes to risk of preterm, low birthweight infants. Pharmacogenetics 2004;14:569-576 (Pubitemid 39281811)
40. Katoh T, Yamano Y, Tsuji M, Watanabe M. Genetic polymorphisms of human cytosol glutathione S-transferases and prostate cancer. Pharmacogenomics 2008;9:93-104 (Pubitemid 351560533)
41. Delpisheh A, Brabin L, Topping J, Reyad M, Tang AW, Brabin BJ. A case-control study of CYP1A1, GSTT1 and GSTM1 gene polymorphisms, pregnancy smoking and fetal growth restriction. Eur J Obstet Gynecol Reprod Biol 2009;143:38-42
42. Grazuleviciene R, Danileviciute A, Nadisauskiene R, Vencloviene J. Maternal smoking, GSTM1 and GSTT1 polymorphism and susceptibility to adverse pregnancy outcomes. Int J Environ Res Public Health 2009;6:1282-1297
43. Price TS, Grosser T, Plomin R, Jaffee SR. Fetal genotype for the xenobiotic metabolizing enzyme NQO1 influences intrauterine growth among infants whose mothers smoked during pregnancy. Child Dev 81,101-114
44. Sasaki S, Sata F, Katoh S, Saijo Y, Nakajima S, Washino N, Konishi K, Ban S, Ishizuka M, and Kishi R. Adverse birth outcomes associated with maternal smoking and polymorphisms in the N-Nitrosamine-metabolizing enzyme genes NQO1 and CYP2E1. Am J Epidemiol 2008;167:719-726
45. Sasaki S, Kondo T, Sata F, Saijo Y, Katoh S, Nakajima S, Ishizuka M, Fujita S, and Kishi R. Maternal smoking during pregnancy and genetic polymorphisms in the Ah receptor, CYP1A1 and GSTM1 affect infant birth size in Japanese subjects. Mol Hum Reprod 2006;12:77-83
46. Luger, K, Mader, AW, Richmond, RK, Sargent, DF, and Richmond, TJ. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 1997;389:251-260 (Pubitemid 27406632)
47. Illingworth RS, Bird AP. CpG islands--'a rough guide'. FEBS Lett 2009;583:1713 1720
48. Biliya S, Bulla LA, Jr. Genomic imprinting: the influence of differential methylation in the two sexes. Exp Biol Med (Maywood) 2010;235,139-147
49. Dvash T, and Fan G Epigenetic regulation of X-inactivation in human embryonic stem cells. Epigenetics 2009;4:19-22
50. Choudhuri S, Cui Y, Klaassen CD. Molecular targets of epigenetic regulation and effectors of environmental influences. Toxicol Appl Pharmacol 245:378-393
51. Pauler FM, Barlow DP. Imprinting mechanisms--it only takes two. Genes Dev 2006;20:1203-1206
52. Jenuwein T, and Allis, CD Translating the histone code. Science 2001;293:1074-1080
53. Lennartsson A, Ekwall K. Histone modification patterns and epigenetic codes. Biochim Biophys Acta 2009;1790:863-868
54. Nakanishi, S, Sanderson, BW, Delventhal, KM, Bradford, WD, Staehling-Hampton, K, Shilatifard, A. A comprehensive library of histone mutants identifies nucleosomal residues required for H3K4 methylation. Nat Struct Mol Biol 2008;15:881-888
55. Ogata, ES, Bussey, ME, and Finley, S. Altered gas exchange, limited glucose and branched chain amino acids, and hypoinsulinism retard fetal growth in the rat. Metabolism 1986;35:970-977
56. Thompson RF, Fazzari MJ, Niu H, Barzilai N, Simmons RA, and Greally JM. Experimental intrauterine growth restriction induces alterations in DNA methylation and gene expression in pancreatic islets of rats. J Biol Chem 2010;285:15111-15118
57. Ke X, Lei Q, James SJ, Kelleher SL, Melnyk S, Jernigan S, Yu X, Wang L, Callaway CW, Gill, G, Chan, GM, Albertine, KH, McKnight, RA, and Lane, RH. Uteroplacental insufficiency affects epigenetic determinants of chromatin structure in brains of neonatal and juvenile IUGR rats. Physiol Genomics2006;25:16-28
58. MacLennan NK, James SJ, Melnyk S, Piroozi A, Jernigan S, Hsu JL, Janke SM, Pham TD, Lane RH. Uteroplacental insufficiency alters DNA methylation, one-carbon metabolism, and histone acetylation in IUGR rats. Physiol Genomics 2004;18:43-50
59. Fu Q, McKnight RA, Yu X, Wang L, Callaway CW, Lane RH. Uteroplacental insufficiency induces site-specific changes in histone H3 covalent modifications and affects DNA-histone H3 positioning in day 0 IUGR rat liver. Physiol Genomics 2004;20:108-116
60. Fu Q, Yu X, Callaway CW, Lane RH, McKnight RA. Epigenetics: intrauterine growth retardation (IUGR) modifies the histone code along the rat hepatic IGF-1 gene. FASEB J 2009;23:2438-2449
61. Park JH, Stoffers DA, Nicholls RD, Simmons RA. Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1. J Clin Invest 2008;118:2316-2324
62. Tamashiro KL, Moran TH. Perinatal environment and its influences on metabolic programming of offspring. Physiol Behav 100:560-566
63. Bocock, PN, and Aagaard-Tillery, KM. Animal models of epigenetic inheritance. Semin Reprod Med 2009;27:369-379
64. Suter MA, Aagaard-Tillery, KM. Environmental influences on epigenetic profiles. Semin Reprod Med 2009;27:380-390
65. Hillemacher T, Frieling H, Moskau S, Muschler MA, Semmler A, Kornhuber J, Klockgether T, Bleich S, Linnebank M. Global DNA methylation is influenced by smoking behaviour. Eur Neuropsychopharmacol 2008;18:295-298
66. Terry MB, Ferris JS, Pilsner R, Flom JD, Tehranifar P, Santella RM, Gamble MV, Susser E. Genomic DNA methylation among women in a multiethnic New York City birth cohort. Cancer Epidemiol Biomarkers Prev 2008;17:2306-2310
67. Breton CV, Byun HM, Wenten M, Pan F, Yang A, Gilliland FD Prenatal tobacco smoke exposure affects global and gene-specific DNA methylation. Am J Respir Crit Care Med 2009;180:462-467
68. Guerrero-Preston, R, Goldman, LR, Brebi-Mieville P, Ili-Gangas C, Lebron C, Hernandez-Arroyo, M, Witter, FR, Apelberg, BJ, Roystacher, M, Jaffe, A, Halden, RU, Sidransky, D. Global DNA hypomethylation is associated with in utero exposure to cotinine and perfluorinated alkyl compounds. Epigenetics 5,2010;5:6
69. Suter M, Abramovici A, Showalter L, Hu M, Shope CD, Varner M, Aagaard-Tillery, K. In utero tobacco exposure epigenetically modifies placental CYP1A1 expression.Metabolism 2010;59:1481-1490
70. Huuskonen P, Storvik M, Reinisalo M, Honkakoski P, Rysa J, Hakkola J, and Pasanen M. Microarray analysis of the global alterations in the gene expression in the placentas from cigarette-smoking mothers. Clin Pharmacol Ther 2008;83:542-550
71. MacArthur C, Knox, EG. Smoking in pregnancy: effects of stopping at different stages. Br J Obstet Gynaecol 1988;95:551-555
72. Kramer, MS. Intrauterine growth and gestational duration determinants. Pediatrics 1987;80:502-511
73. Wen SW, Goldenberg RL,Cutter GR, Hoffman HJ, Cliver SP, Davis RO, DuBard, MB. Smoking, maternal age, fetal growth, and gestational age at delivery. Am J Obstet Gynecol 1990;162:53-58
74. Friend, K, and Levy, DT. Smoking treatment interventions and policies to promote their use: a critical review. Nicotine Tob Res 2001;3:299-310 (Pubitemid 33101057)
75. Odegard RA, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R. Risk factors and clinical manifestations of pre-eclampsia. BJOG 2000;107:1410-1416
76. Meyer, MB, Tonascia, JA. Maternal smoking, pregnancy complications, and perinatal mortality. Am J Obstet Gynecol 1977;128:494-502
77. MacDorman MF, Cnattingius S, Hoffman HJ, Kramer MS, Haglund B. Sudden infant death syndrome and smoking in the United States and Sweden. Am J Epidemiol 1997;146:249-257 (Pubitemid 27329726)
78. Mitchell EA, Scragg R, Stewart AW, Becroft DM, Taylor BJ, Ford RP, Hassall IB, Barry DM, Allen EM, and Roberts AP. Results from the first year of the New Zealand cot death study. N Z Med J 1991;104:71-76
79. Froen JF Arnestad M, Frey K, Vege A, Saugstad OD, Stray-Pedersen B. Risk factors for sudden intrauterine unexplained death: epidemiologic characteristics of singleton cases in Oslo, Norway, 1986-1995. Am J Obstet Gynecol 2001;184:694-702
80. Stephansson O, Dickman PW, Johansson AL, Cnattingius S The influence of socioeconomic status on stillbirth risk in Sweden. Int J Epidemiol 2001;30:1296-1301